Overactive bladder
Conditions
Interventions
micro radiofrequency therapy:micro radiofrequency therapy
Tolterodine:Oral tolterodine
Sponsors
The First Affiliated Hospital of Nanjing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1)Age = 18 years. (2)Patients meeting criteria for moderate to severe OAB. (3)Normal upper urinary tract function, bladder capacity > 100ml. (4)Voluntary participation in the trial with written informed consent. (5)Able to communicate with the investigators and willing to comply with the requirements of the trial.
Exclusion criteria
Exclusion criteria: (1)Pregnant or lactating women. (2)Patients with secondary OAB symptoms such as urinary tract obstruction. (3)Patients with uncontrolled urinary system infection within 1 week. (4)Patients with renal insufficiency and serum creatinine greater than 1.5 times of normal value. (5)Patients with surgical contraindications. (6)Patients with any implanted neurostimulator, cardiac pacemaker or implantable defibrillator. (7)Presence of concomitant diseases seriously affecting health, such as malignant tumor. (8)Patients who have received botulinum toxin treatment in the past 12 months. (9)Patients allergic to latex materials. (10)Presence of other concomitant disease affecting the efficacy of the trial. (11)Patients who participated in other clinical trials 3 months before the trial. (12)Other conditions that the investigator considers inappropriate for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| mean volume per micturition per 24 hours;OABSS;QoL score; | — |
Countries
China
Contacts
Public ContactXiaoxin Meng
The First Affiliated Hospital of Nanjing Medical University
Outcome results
None listed